CLINICAL_TRIALS
trial_result
· 2014-08-06
Clinical Trial Update: Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA) [Phase 4]
Summary
The ELECTRA Phase 4 trial evaluating dronedarone use in patients scheduled for elective cardioversion for atrial fibrillation has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED